Md Yuzaiful Md Yusof
2 years 11 months ago
#ACR23 Year in Review. CAR-T cell showed promising results in #SLE based on case series but extrapolation to other RMD may be challenging.
-Myositis recurred after 7days, needing MMF
-No improvement in lung fibrosis #SSc
Longer-term data & trial data are needed @RheumNow https://t.co/4Zmjvr51Ab
Mike Putman EBRheum
2 years 11 months ago
More good data for benralizumab (IL5i) in EGPA, @TerrierBen
There may be additional benefit over MEPO given deeper eosinophil depletion
Checkout our recent editorial about this in @TheLancetRheum
@RheumNow #ACR23 https://t.co/1d2nITOuOs
Dr. Antoni Chan
2 years 11 months ago
Our work showed the PSAID-12 score done remotely correlated with in-person clinic assessment of tender (r=0.58) , swollen joint count (r= 0.51), pain (r=0.84). 21% of patients had low disease activity onPSAID12 assessment, Chan A #Abst0507 #ACR23 @RheumNow https://t.co/vorth2ko39 https://t.co/Q2Y3ApD47E
Aurelie Najm
2 years 11 months ago
Why do we do translational research?
Dr Mustelin outlines different goals of basic science in #yearinreview
I would emphasize the #1: understanding pathogenesis is key to address clinical challenges
Overall “we have much more work to do than we care to admit”
@RheumNow #ACR23 https://t.co/QtBO3Go3gD
sheila
2 years 11 months ago
Year in review: Long-term outcome of pts in the MAINRITSAN trials
Better outcome in pts who received RTX every 6 months for 18 months.
Implications? May consider shorter duration of maintenance tx (<36mos)?
#ACR23 @RheumNow #vasculitis https://t.co/18cXBlfxSG
Dr. Rachel Tate
2 years 11 months ago
Great Dr. Seo presents a great quote from Prof Seza Ozen during #ACR23 YiR "What you think of as a rare manifestation of a common disease is probably a common presentation of a disease you are not aware of (yet.)" A call to arms to continue to be curious! @RheumNow https://t.co/zVcIpHZznt
Mike Putman EBRheum
2 years 11 months ago
RTX-induction subgroup, ADVOCATE
Encouraging results (remission 71% vs 56% plbo wk 52), but never forget RTX was NOT redosed at month 6, so pts randomized to prednisone had NO TREATMENT from wk 20 - wk 52
Take results w/grain of salt
@RheumNow #ACR23 #ACRBest @anisha_dua https://t.co/zVhRX3IbiL
Mike Putman EBRheum
2 years 11 months ago
Regarding monitoring of ILD: "TLC takes a lot of time and is not necessary for follow up PFTs" @sclerodermaUM
Very nice pearl; I have been including TLC in subsequent PFTs, probably not necessary
Will change my practice immediately & save patients time
@RheumNow #ACR23
The window of opportunity concept in RA shifted our focus to trying to treat disease earlier and more aggressively to improve long term outcomes. A natural development of this was to reconsider the possibility of therapeutic interventions aimed at the prevention of rheumatoid arthritis.
Of the many exciting advancements for patients with psoriatic arthritis at ACR Convergence, one upcoming therapy stood out: the dual IL-17A/F inhibitor bimekizumab. Nearly two dozen bimekizumab abstracts will be featured at this year’s meeting and it recently received authorization in Europe and the U.S. for psoriasis. That makes this the year I plan to figure out where this drug will be useful for my patients with PsA.
TheDaoIndex KDAO2011
2 years 11 months ago
The gut matters and take care of your dental health! #Yearinreview Microbiomes and RA:
1. Changing gut micro biome in mice immediately triggers inflammatory arthritis
2. Mucosal breaks allow bacteria in and trigger citrullination. #ACR23 @RheumNow https://t.co/Iini9yE8dJ
Md Yuzaiful Md Yusof
2 years 11 months ago
#ACR23 Year in Review. Dr Seo did a great job in highlighting key papers.
#SLE #Tyk2 Phase 2 RCT of Deucravacitinib recruited pts of diverse ancestry. More pts on DEUC met SRI-4 response vs PBO. Question remains about the inverse/flat dose response. Going to Phase 3 @RheumNow https://t.co/68rYjEnWyN
Aurelie Najm
2 years 11 months ago
More studies emphasizing the role of microbiome in RA
1- Directly arthritogenic microbe strain confirmed in mice model
2- Gingivitis and oral microbiome can trigger citrullination and ACPA production
Dr Tomas Mustelin #yearinreview
@RheumNow #ACR23 https://t.co/uBd1UEgLRz
sheila
2 years 11 months ago
Vitamin D and bone health 🦴
Dr. Connie Weaver discusses the effect of Vit D on bone as well as dietary recomms fr diff groups.
Are your pts at risk of Vit d deficiency?👇
#ACR23 @RheumNow @rheumarhyme https://t.co/XcopyBHAoj
Meral K. El Ramahi, MD MeralElRamahiMD
2 years 11 months ago
Delighted to be joining my colleagues below to reporting on #ACR23 for @Rheumnow.
Tune-in for coverage and follow my colleagues below as well! https://t.co/rdLZbPGj3O https://t.co/hhwYf4YyLv
